Jon Cunningham

Can AI automate HF adjudication in global clinical trials?

Our latest #AHA2024 SimPub @CircHF

In the DELIVER trial, our AI model for HF hosp was
-Accurate
-Generated identical treatment estimate for dapa as human CEC
-Extracts evidence of HF

Paper: twtr.to/7qxb_

Thanks to hosts @DrMerkely & @KosztinMd for inviting me to speak at the Semmelweis University Symposium in Budapest on AI in cardiovascular care

Enjoyed speaking with members of the Hungarian cardiology community and global colleagues like @NirUrielMD

Photo @LuHenri8

Out today in @JACCJournals & #AHA25, led by
@PabloMikiMarti

Auto-MACE: automated AI adjudication model for MACE (CV death, MI, & stroke)

Strong agreement with CEC in PARADISE-MI trial. Recognizes uncertain events.

tinyurl.com/3w33dyec

Doubleheader week for all-star nephrologist and mentee @SBadrouchi

Spreading the word about improving CKM clinical trials with AI

#KidneyWk: Generative AI for Event Adjudication
#AHA25: Extracting individual symptoms, signs, and treatment from unstructured medical records

Aldosterone synthase inhibitors offer an alternative strategy to target a classic pathway in hypertension, renal, and CV disease

In @MedCellPress, @lamcardio and I review recent ASI trials in hypertension and future evaluation in HF & CKD

authors.elsevier.com/c/1lPvv9UKeTpc…